- Home
- CANF vs BQ Comparison
CANF vs BQ Comparison
Compare CANF & BQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CANF | BQ |
|---|---|---|
| Founded | 1994 | 2008 |
| Country | Israel | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.7M | 7.7M |
| IPO Year | 2011 | 2020 |
Fundamental Metrics
Financial Performance| Metric | CANF | BQ |
|---|---|---|
| Price | $2.28 | $0.83 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $50.00 | N/A |
| AVG Volume (30 Days) | 180.7K | ★ 4.7M |
| Earning Date | 03-26-2026 | 01-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $2,715,455.50 | N/A |
| Revenue Next Year | $101.06 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.17 | $0.65 |
| 52 Week High | $10.40 | $72.74 |
Technical Indicators
Market Signals| Indicator | CANF | BQ |
|---|---|---|
| Relative Strength Index (RSI) | 27.53 | 41.02 |
| Support Level | $0.17 | $0.70 |
| Resistance Level | $3.59 | $0.89 |
| Average True Range (ATR) | 0.14 | 0.05 |
| MACD | -0.13 | -0.02 |
| Stochastic Oscillator | 1.54 | 2.11 |
Price Performance
Historical ComparisonAbout CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.
About BQ Boqii Holding Limited representing
Boqii Holding Ltd is a pet-focused platform in China. It offer a truly one-stop destination that pet parents in China may go to get everything it need for their pets and share their passion for pet parenting. It operate a pet-focused online retail business in China's pet market in terms of GMV. The company operates in single segment. This segment is engaged in pet products sales and online marketing and information services and other. All the company's revenues is derived from The PRC.